Yoshiro Maezawa

Has grant

Lecturer

Chiba University

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Medical Science Medical Science professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Yoshiro Maezawa is a Lecturer at Chiba University, Japan. His research areas focus on genetic testing and cancer screening in Werner syndrome, as well as innovative diagnostic techniques for pneumonia and diabetes management. Recent articles include investigations into dyslipidemia in diabetic patients and the impact of weight loss on inflammation in those at risk for cardiovascular events.

Recent Grants

Grant: Close

糖尿病の血管合併症におけるPericyte老化の役割の解明

Open Date: 2020-04-01

Close Date: 2023-03-31

Grant: Close

転写因子Tcf21の機能解析を通じた腎線維化の病態解明

Open Date: 2017-04-01

Close Date: 2020-03-31

Grant: Close

The role of Tcf21 in Podocytes in Health and Diseases

Open Date: 2014-04-01

Close Date: 2017-03-31

Articles (14)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (4)

Yuumi Nakamura

JAPAN

View details

Hisaya Kato

Assistant Professor

Chiba University Graduate School of Medicine

JAPAN

View details

Takumi Kitamoto

Assistant professor

Chiba University

JAPAN

View details

Tuncer Onay

Research Assistant Professor

Northwestern University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Yoshiro Maezawa

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (14)

For early diagnosis of young patients with Werner syndrome: Indication for genetic testing

Recommendations for cancer screening and surveillance in patients with Werner syndrome

Novel technique of measuring diaphragm thickness using computed tomography and its potential for predicting prognosis of pneumonia

Urinary α1 microglobulin level is useful for selecting sodium‐glucose transporter 2 inhibitor or metformin for visceral fat reduction in patients with type 2 diabetes

Updates on dyslipidemia in patients with diabetes

Weight loss improves inflammation by T helper 17 cells in an obese patient with psoriasis at high risk for cardiovascular events

Sex differences in symptom presentation and their impact on diagnostic accuracy in Werner syndrome.

Stromal Transcription Factor 21 Regulates Development of the Renal Stroma via Interaction with Wnt/β-Catenin Signaling

A high prevalence of myeloid malignancies in progeria with Werner syndrome is associated with p53 insufficiency

Central administration of sodium-glucose cotransporter-2 inhibitors increases food intake involving adenosine monophosphate-activated protein kinase phosphorylation in the lateral hypothalamus in healthy rats

Effects of Sodium Glucose Co-Transporter 2 Inhibitors in Type 1 Diabetes Mellitus on Body Composition and Glucose Variabilities: Single-Arm, Exploratory Trial.

A novel podocyte protein, R3h domain containing-like, inhibits TGF-β-induced p38 MAPK and regulates the structure of podocytes and glomerular basement membrane.

Effects of ipragliflozin versus metformin in combination with sitagliptin on bone and muscle in Japanese patients with type 2 diabetes mellitus: Subanalysis of a prospective, randomized, controlled study (PRIME‐V study)

Fibroblasts from different body parts exhibit distinct phenotypes in adult progeria Werner syndrome.

Collaborators (4)

Yuumi Nakamura

Hisaya Kato

Takumi Kitamoto

Tuncer Onay

Make your next move.